Dagenais, R., Wilby, K. J., Elewa, H., & Ensom, M. H. H. (2017). Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region. Drugs in R&D, 17(3), 341. https://doi.org/10.1007/s40268-017-0195-7
Chicago Style (17th ed.) CitationDagenais, Renée, Kyle John Wilby, Hazem Elewa, and Mary H. H. Ensom. "Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region." Drugs in R&D 17, no. 3 (2017): 341. https://doi.org/10.1007/s40268-017-0195-7.
MLA (9th ed.) CitationDagenais, Renée, et al. "Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region." Drugs in R&D, vol. 17, no. 3, 2017, p. 341, https://doi.org/10.1007/s40268-017-0195-7.